WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Communicating Multiple Disease Risks: A Translation of Risk Prediction Science

Not Applicable

Completed

Conditions: Healthy Volunteers

Interventions: Behavioral: Risk Assessment App
Other: Surveys
Behavioral: Audio Recording - Sleep
Behavioral: Audio Recording - Exercise
Other: Text message reminders
Other: Text Message Survey

First Posted Date: 2017-08-21

Last Posted Date: 2020-01-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 554

Registration Number: NCT03255291

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Lidocaine for Oxaliplatin-induced Neuropathy

Phase 1

Completed

Conditions: Neuropathy, Painful
Chemotherapy-induced Peripheral Neuropathy
Colorectal Cancer

Interventions: Drug: Placebo
Drug: Lidocaine Hydrochloride
Drug: FOLFOX regimen

First Posted Date: 2017-08-18

Last Posted Date: 2022-03-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 26

Registration Number: NCT03254394

Locations: 🇺🇸
Washington University School of Medicine/Barnes Jewish Hospital, Saint Louis, Missouri, United States

N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes

Early Phase 1

Completed

Conditions: Lower Limb Amputation Knee
Diabetes Mellitus
Critical Limb Ischemia
Peripheral Arterial Disease

Interventions: Drug: Active Arm N-acetyl cysteine (NAC)
Drug: Placebo Arm

First Posted Date: 2017-08-17

Last Posted Date: 2024-08-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 33

Registration Number: NCT03253328

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

Not Applicable

Recruiting

Conditions: Deep Vein Thrombosis
Venous Leg Ulcer
Post Thrombotic Syndrome
Venous Stasis
Venous Insufficiency
Venous Reflux

Interventions: Device: Stents

First Posted Date: 2017-08-15

Last Posted Date: 2025-02-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 250

Registration Number: NCT03250247

Locations: 🇺🇸
St. Louis University Hospital, Saint Louis, Missouri, United States
🇺🇸
University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸
UCLA, Los Angeles, California, United States

and more 40 locations

Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use

Terminated

Conditions: Pain, Chronic
Opioid Use

Interventions: Other: post-surgical opioid use measured at 1 day and 1 week.

First Posted Date: 2017-08-14

Last Posted Date: 2020-10-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT03248765

Locations: 🇺🇸
Washington University in St Louis School of Medicine, Saint Louis, Missouri, United States

Pediatric Urology Recovery After Surgery Endeavor (PURSUE)

Active, not recruiting

Conditions: Urinary Bladder Diseases
Urologic Surgical Procedures
Urinary Bladder, Neurogenic

Interventions: Other: Enhanced Recovery after Surgery
Other: Historical usual surgical care

First Posted Date: 2017-08-10

Last Posted Date: 2024-10-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 85

Registration Number: NCT03245242

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸
Ann & Robert Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

and more 4 locations

Silver Nanoparticle Investigation for Treating Chronic Sinusitis

Phase 1

Withdrawn

Conditions: Chronic Rhinosinusitis (Diagnosis)

Interventions: Drug: Colloidal silver nanoparticles
Other: Purified Water

First Posted Date: 2017-08-08

Last Posted Date: 2018-05-11

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03243201

A Study Examining the Medication Apremilast as Treatment for Chronic Itch

Phase 2

Completed

Conditions: Itch

Interventions: Drug: Apremilast

First Posted Date: 2017-08-03

Last Posted Date: 2021-07-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT03239106

Locations: 🇺🇸
Washington University Division of Dermatology, Saint Louis, Missouri, United States

Predictors of AAA Expansion and/or Rupture

Phase 4

Terminated

Conditions: Abdominal Aortic Aneurysm (AAA)

Interventions: Drug: Assess AAA rupture risk by PET-CTA scans
Drug: 18F-fludeoxyglucose (FDG)
Diagnostic Test: 11C-PBR28

First Posted Date: 2017-07-27

Last Posted Date: 2021-07-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT03231397

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

Phase 1

Completed

Conditions: Mammoplasty
Breast Implant Infection

Interventions: Other: Normal saline
Procedure: Skin biopsy
Drug: Cefazolin
Procedure: Bilateral skin- or nipple-sparing mastectomies
Device: Breast implant
Device: Tissue expander
Procedure: Autologous flap
Other: Acellular dermal matrix sling
Drug: Gentamicin
Drug: Bacitracin

First Posted Date: 2017-07-11

Last Posted Date: 2019-02-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 19

Registration Number: NCT03213249

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy